Recombinant Mouse Tet2 Protein ，His & KSI

TET2 (Tet Methylcytosine Dioxygenase 2) is a member of the TET family of enzymes that play a critical role in the active demethylation of DNA, thereby influencing gene expression and cellular differentiation. Aberrant TET2 function has been implicated in various hematological malignancies, particularly acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Mutations and dysregulation of TET2 are frequently observed in these conditions, highlighting its importance in hematopoiesis and tumorigenesis. Research on TET2 recombinants has gained momentum as scientists aim to elucidate its biochemical mechanisms and interactions with other epigenetic regulators. The study of TET2 recombinant proteins provides insights into their structural and functional properties, which are critical for understanding how TET2-mediated DNA demethylation processes can influence cancer progression and treatment responses. Furthermore, advances in recombinant DNA technology allow for the generation of TET2 variants, enabling the exploration of specific mutation effects and the design of potential therapeutic approaches targeting this enzyme in malignancies. Ultimately, a deeper understanding of TET2 function through recombinant studies may pave the way for novel epigenetic therapies aimed at re-establishing normal gene expression patterns in cancer cells.